UBS analysts initiated coverage on GSK plc (NYSE:GSK) with a Neutral rating on January 23, 2026.
GSK plc operates in the Healthcare sector. The stock currently trades at $49.15 with a market capitalization of $99.4B.
new coverageNYSE:GSK
UBS Initiates Coverage on GSK plc (GSK) with Neutral
UBS analysts initiated coverage on GSK plc (NYSE:GSK) with a Neutral rating on January 23, 2026. GSK plc operates in the Healthcare sector. The stock currently trades at $49.15…
